Invention Grant
- Patent Title: Chemically ligated RNAs for CRISPR/Cas9-1gRNA complexes as antiviral therapeutic agents
-
Application No.: US16029653Application Date: 2018-07-09
-
Publication No.: US11667914B2Publication Date: 2023-06-06
- Inventor: Minghong Zhong
- Applicant: Minghong Zhong
- Applicant Address: US PA Sellersville
- Assignee: Minghong Zhong
- Current Assignee: Minghong Zhong
- Current Assignee Address: US PA Sellersville
- Main IPC: C12N15/11
- IPC: C12N15/11 ; C12N15/113 ; A61K38/17 ; A61K31/7105 ; C12N9/96 ; A61K38/00

Abstract:
Provided herein are chemically ligated guide RNA oligonucleotides (lgRNA) which comprise two functional RNA modules (crgRNA and tracrgRNA) joined by non-nucleotide chemical linkers (nNt-linker), their complexes with CRISPR-Cas9, preparation methods of Cas9-lgRNA complexes, and their uses for prevention and treatments of herpesvirus infections in humans. Also disclosed are processes and methods for preparation of these compounds.
Public/Granted literature
- US20220290135A9 Chemically Ligated RNAs for CRISPR/Cas9-lgRNA Complexes as Antiviral Therapeutic Agents Public/Granted day:2022-09-15
Information query
IPC分类: